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###### 

Characteristics and lipid profile in 76 HIV-infected patients who developed dyslipidemia after ART treatment in Taoyuan, Taiwan

  Characteristics                                                                                       Patients number or mean   Percentage (SD)
  ----------------------------------------------------------------------------------------------------- ------------------------- -----------------
  Total number                                                                                          76                        100%
  Female                                                                                                11                        14.5%
  Age                                                                                                   36.1                      (8.9)
  Body mass index                                                                                       22.94                     (3.79)
  HIV transmission category                                                                                                       
  Injection drug users                                                                                  11                        14.5%
  Heterosexual                                                                                          13                        26.3%
  Men who have sex with men                                                                             52                        68.4%
  Nadir CD4 T cell counts                                                                               220.9 (median 136)        (249.5)
  Nadir HIV viral load (log10)                                                                          4.95                      (0.92)
  Years between HIV diagnosis and regimen modification                                                  3.09                      (2.89)
  Fibrate added on                                                                                      16                        21.5%
  Statin added on                                                                                       64                        84.2%
  Switch to lipid-friendly ART after lipid-lowering agents                                              13                        17.1%
  Baseline total cholesterol/triglyceride/high-density lipoprotein/low-density lipoprotein (mg/dL)      279/422/45/139            (85/618/15/57)
  4--12 weeks total cholesterol/triglyceride/high-density lipoprotein/low-density lipoprotein (mg/dL)   209/270/47/114            (42/292/15/41)
  48 weeks total cholesterol/triglyceride/high-density lipoprotein/low-density lipoprotein (mg/dL)      206/250/44/121            (41/205/13/36)
